Author

Maud Majeres Lugand

Observed names: Lugand, Maud Majeres, Maud Lugand, Maud Lugand Majeres, Maud M. Lugand, Maud Majeres-Lugand

Institution: Medicines for Malaria Venture

Observed institution: Medicines for Malaria Venture

ORCID: 0009-0001-6700-1441

Observed ORCID: 0009-0001-6700-1441

OpenAlex ID: A5015952408

Global Call to Action: maximize the public health impact of intermittent preventive treatment of malaria in pregnancy in sub-Saharan Africa

2015 · R Matthew Chico, Stephanie Dellicour, et al. · Malaria Journal · 34

Global Call to Action to scale-up coverage of intermittent preventive treatment of malaria in pregnancy: seminar report

2015 · Koki Agarwal, Pedro Alonso, et al. · Malaria Journal · 29

Closing the access barrier for effective anti-malarials in the private sector in rural Uganda: consortium for ACT private sector subsidy (CAPSS) pilot study

2012 · Ambrose O Talisuna, Penny Grewal Daumerie, et al. · Malaria Journal · 28

Participatory research for the development of information, education and communication tools to promote intermittent preventive treatment of malaria in pregnancy in the Democratic Republic of the Congo, Nigeria and Mozambique

2021 · Sylvain Landry Birane Faye, Maud Majeres Lugand · Malaria Journal · 21

Overcoming the affordability barrier for effective and high quality life saving malaria medicines in the private sector in rural Uganda: the Consortium for ACT Private Sector Subsidy (CAPSS) pilot study

2012 · Ambrose O Talisuna, Penny Grevval, et al. · Malaria Journal · 17

The five continuum of care criteria that should accompany rectal artesunate interventions: lessons learned from an implementation study in Malawi

2023 · Monique S. Oliff, Pamela Muniina, et al. · Malaria Journal · 3

Field testing of user-friendly perennial malaria chemoprevention packaging in Benin, Côte d’Ivoire and Mozambique

2024 · Sylvain Landry Birane Faye, Maud Majeres Lugand, et al. · Malaria Journal · 2

Improving malaria chemoprevention coverage in pregnancy: Surveying stakeholder preferences for new product profiles and community-delivery approaches across five African countries

2026 · Céline Audibert, Isabelle Borghini-Fuhrer, et al. · PLOS Global Public Health · 1

Initiating community intermittent preventive treatment of malaria in pregnancy in Senegal: qualitative evaluation of stakeholder acceptability and experience

2025 · Tidiane Ndoye, Maud Majeres Lugand, et al. · Malaria Journal · 1

ICH E21: from landmark guidance to specific action for maternal and child health

2026 · Myriam El Gaaloul, The Collaborative Group on Global Maternal and Child Health, et al. · Journal of Translational Medicine

Correction: Initiating community intermittent preventive treatment of malaria in pregnancy in Senegal: qualitative evaluation of stakeholder acceptability and experience

2026 · Tidiane Ndoye, Maud Majeres Lugand, et al. · Malaria Journal

Development of Context-Appropriate Recruitment and Retention Approaches for Pregnant Women in the SAFIRE Clinical Trial Assessing Safety and Efficacy of Artemisinin-Combination Therapies: A Formative Research Protocol

2026 · Jenna Hoyt, Adélaïde Compaoré, et al. · International Journal of Qualitative Methods

Works count: 14

Citation count: 136

H-index: 5

I10-index: 5